Search Results for "RHD82101"

FAQs – Hybridoma

Monoclonal antibodies are invaluable tools for research, therapy, and diagnostics. Hybridoma development has, for many years, been considered one of the best methods to produce highly specific and high-affinity antibodies for multiple applications. On this page,… Read More

Download the complete Hybridoma development report – ELISA

Download the complete Hybridoma development report - ELISA Request the complete Hybridoma development – ELISA PDF file and discover: an example of report you could get by choosing ProteoGenix as your hybridoma development partner, the full-set of data including additional analysis. Read More

Download the complete Hybridoma development report – FC

Download the complete Hybridoma development report - FC Request the complete Hybridoma development – FC PDF file and discover: an example of report you could get by choosing ProteoGenix as your hybridoma development partner, the full-set of data including additional analysis. Read More

Chargé(e) d’affaires – Synthèse de gènes et production d’anticorps polyclonaux

Type d’offre : Emploi à plein temps   Vous rejoignez une société de biotechnologie créée en 2003 dont le chiffre d’affaires affiche une croissance moyenne de 20 à 50% par an. ProteoGenix commercialise des produits et services dans le domaine des biotechnologies à… Read More

Hybridoma production for therapeutic applications

Creating potent immunotherapies? boost efficiencies with our hybridoma platform From antigen design to the clinic >98% success rate on more than 500 projects 3 Therapeutic antibodies on the market Creating potent immunotherapies? boost efficiencies with our hybridoma platform From… Read More

How are hybridoma cells produced?

The first antibodies ever produced in vitro were murine monoclonal antibodies obtained using the hybridoma technology in 1975. Hybridomas have since become one of the most relevant technologies for antibody discovery. By leveraging the highly cost-effective and efficient process of affinity maturation, hybridoma-generated antibodies continue to be one… Read More

How are monoclonal antibodies produced by hybridomas?

Hybridomas are tools for antibody discovery and production. They allow the capture and immortalization of highly productive plasma cells (effector B cells) able to secrete large quantities of antibodies. However, the production of monoclonal antibodies in hybridomas needs to be tailored for each specific clone. In this article,… Read More

Ascites and hybridoma cell culture antibody production

Frustrated by the antibody yield of your hybridomas? Hybridoma cell culture or ascites production 40 mg/L yield guaranteed Endotoxin free (<1EU/mg) Frustrated by the antibody yield of your hybridomas? Hybridoma cell culture or ascites production 40 mg/L yield guaranteed Endotoxin free (<1EU/mg) … Read More

ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases

ProteoGenix Receives European Funding to Develop a Therapeutic Antibody for the Treatment of Inflammatory Rheumatic Diseases April 12, 2021 In a project coordinated by ImmunOs Therapeutics AG and in partnership with Amsterdam UMC, ProteoGenix prepares to tackle an unmet medical need and alleviate the burden… Read More

FAQs – Monoclonal antibodies

Monoclonal antibodies are recognized for their safety, high specificity and binding affinity, and structural stability. Given their advantageous properties and structure, they are useful for a multitude of applications like therapy, diagnostics (in vitro and medical devices), and research (basic, clinical, environmental, etc.). Read More